US FDA Grants Rare Pediatric Disease Designation (RPDD) to Pax...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SYDNEY, NSW, Aug. 7, 2020 /PRNewswire-AsiaNet/-- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Ka...
Authors: LATEST ASIANET NEWS RELEASES